Sage Group falls Thursday, underperforms market
Shares of Sage Group PLC SGE dropped 1.17% to £13.04 Thursday, on what proved to be an all-around rough trading session for ...
Q1 EPS Forecast for Sage Therapeutics Boosted by Analyst
Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Sage Therapeutics in a ...
Biogen Q4 Earnings Review: Why I'm Calling Time On This 'Powder Puff' Pharma
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Sage Therapeutics’ (SAGE) “Hold” Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Wednesday,Benzinga reports. Other equities ...
kalkinemedia6d
Is Sage Therapeutics (NASDAQ:SAGE) Facing a Turning Point in the Market?
Highlights,Institutional investors have adjusted their holdings in Sage Therapeutics.,The company reported a negative net ...
SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial
In a report released today, Joon Lee from Truist Financial maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report). The ...
Biogen details pipeline culling as it looks for more deals like HI-Bio acquisition
Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...
Sage stock price target cut to $12 by H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao revised the price target for Sage Therapeutics (NASDAQ:SAGE) to $12.00 from the previous $14.00 while maintaining a Neutral rating on the company's shares. Tsao's ...
Canaccord cuts Sage Therapeutics price target to $8, holds rating
Canaccord Genuity has adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) by reducing the stock's price target to $8.00 from the previous $9.00, while maintaining a Hold rating on the shares. The ...